Argentus Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
BIT
BFA
Argentus Capital Management's ABBV Position: Q4 2016 in Review
Argentus Capital Management sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 11,828 shares — an estimated $746K sold.
Argentus Capital Management first reported a position in ABBV in Q2 2013 and held it in 14 quarters. The position peaked at $4.48M in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.
- Argentus Capital Management reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
- Argentus Capital Management sold 11,828 AbbVie shares in Q4 2016, an estimated $746K.
- Argentus Capital Management first reported a position in AbbVie in Q2 2013 and held it in 14 quarters.
- Argentus Capital Management's AbbVie position peaked at $4.48M in Q2 2015.
- 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.
Based on Argentus Capital Management's 13F filing for Q4 2016.